Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2335]

ASCO 2023: Radiation can be safely omitted in select patients with locally advanced rectal cancer

ASCO 2023: Radiation can be safely omitted in select patients with locally advanced rectal cancer

ASCO 2023: Study may provide clues to treating colorectal cancer more effectively in younger patients

ASCO 2023: Study may provide clues to treating colorectal cancer more effectively in younger patients

ASCO 2023: For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results

ASCO 2023: For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results

ASCO 2023: Targeted therapy induces responses in HER2-amplified biliary tract cancer

ASCO 2023: Targeted therapy induces responses in HER2-amplified biliary tract cancer

NCCN joins collaboration to improve standards in cancer care for vietnam

NCCN joins collaboration to improve standards in cancer care for vietnam

ASCO 2023: Types of bacteria vary widely in tumours of people with early vs. late-onset colorectal cancer

ASCO 2023: Types of bacteria vary widely in tumours of people with early vs. late-onset colorectal cancer

Colon cancer: Curcumin activates tumour suppressive signalling pathway

Colon cancer: Curcumin activates tumour suppressive signalling pathway

ASCO 2023: Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumours

ASCO 2023: Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumours

HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer

HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer

Scientists first to test cancer drugs in space using private astronaut mission

Scientists first to test cancer drugs in space using private astronaut mission

More from ecancer